ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,159Medicare Part D Prescriptions Filled, Including Refills

Rank: 134 out of 3734

$955K Total Retail Price of All Prescriptions

Rank: 122 out of 3734

600 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 600 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 600 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 12,339 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LISINOPRIL 626 458 1 3
SIMVASTATIN 604 496 2 1
LEVOTHYROXINE SODIUM 453 346 3 2
OMEPRAZOLE 441 349 4 4
AMLODIPINE BESYLATE 429 399 5 5
FUROSEMIDE 396 348 6 7
METFORMIN HCL 355 250 7 8
METOPROLOL TARTRATE 339 280 8 6
HYDROCODONE-ACETAMINOPHEN 270 140 S3 9 12
METOPROLOL SUCCINATE 268 225 10 14
ATENOLOL 265 228 11 13
NEXIUM 258 206 12 36
POTASSIUM CHLORIDE 218 159 13 19
ALENDRONATE SODIUM 213 203 14 26
DONEPEZIL HCL 207 207 15 25
LOVASTATIN 190 158 16 41
ESCITALOPRAM OXALATE 186 166 17 68
NAMENDA 184 184 18 44
HYDROCHLOROTHIAZIDE 176 136 19 9
ATORVASTATIN CALCIUM 174 115 20 11
WARFARIN SODIUM 172 149 21 10
PREDNISONE 166 113 22 42
FENTANYL 162 109 S2 23 65
TAMSULOSIN HCL 158 124 24 29
GLIPIZIDE 158 138 24 57
TRAMADOL HCL 158 115 24 20
SERTRALINE HCL 156 112 27 18
ZOLPIDEM TARTRATE 151 110 28 24
DIOVAN 132 128 29 31
TRIAMTERENE-HCTZ 129 124 30 73
DIGOXIN 129 117 30 43
CITALOPRAM HBR 127 86 32 16
ISOSORBIDE MONONITRATE ER 121 121 33 34
CARVEDILOL 120 114 34 30
LOSARTAN POTASSIUM 118 113 35 21
PRAVASTATIN SODIUM 114 97 36 15
GABAPENTIN 110 59 37 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 107 68 38 27
CRESTOR 106 85 39 28
CELEBREX 104 95 40 69
LANTUS 103 54 41 54
OXYCODONE HCL-ACETAMINOPHEN 102 17 S2 42 122
PAROXETINE HCL 101 46 43 59
CYMBALTA 98 48 44 67
FAMOTIDINE 97 94 45 60
ALLOPURINOL 96 73 46 33
DIOVAN HCT 87 65 47 72
GLIMEPIRIDE 86 62 48 37
PROAIR HFA 83 49 49 83
SPIRONOLACTONE 81 45 50 80
LEXAPRO 80 71 51 236
POLYETHYLENE GLYCOL 3350 79 62 52 53
JANTOVEN 78 71 53 76
AMLODIPINE BESYLATE-BENAZEPRIL 74 67 54 56
CLONIDINE HCL 66 57 55 79
OXYCONTIN 66 30 S2 55 121
LYRICA 66 50 55 124
LEVETIRACETAM 66 46 55 105
TRAZODONE HCL 66 49 55 49
OXYCODONE-ACETAMINOPHEN 65 32 S2 60 51
ATENOLOL-CHLORTHALIDONE 63 63 61 178
BYSTOLIC 62 59 62 148
INSULIN SYRINGE 61 39 63 109
VERAPAMIL ER 61 51 63 96
FLUOXETINE HCL 61 32 63 61
FENOFIBRATE 60 46 66 81
AZITHROMYCIN 58 41 67 38
ZETIA 58 58 67 55
LIPITOR 57 49 69 90
DETROL LA 56 53 70 153
SYNTHROID 56 35 70 47
SPIRIVA 55 40 72 40
KLOR-CON M20 55 48 72 48
CIPROFLOXACIN HCL 55 43 72 77
LEVOFLOXACIN 54 40 75 116
FINASTERIDE 54 54 75 88
BACLOFEN 53 0 77 142
VENLAFAXINE HCL ER 53 13 77 84
CLOPIDOGREL 53 49 77 23
VENTOLIN HFA 53 28 77 70
QUETIAPINE FUMARATE 50 17 81 82
GLIPIZIDE XL 50 41 81 85
CYCLOBENZAPRINE HCL 50 11 R 81 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.